Intellia Therapeutics Vs. Editas Medicine Industry Stock Comparison

Sell

23

NTLA
Intellia Therapeutics

Last Price:

22.44

Seasonality Move:

1.88%

Sell

40

EDIT
Editas Medicine

Last Price:

3.85

Seasonality Move:

2.24%

Sell

23

Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

The current Intellia Therapeutics [NTLA] share price is $21.51. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

40

Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

The current Editas Medicine [EDIT] share price is $3.83. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

The Intellia Therapeutics share price today is $21.51
The current trend is relatively stagnant and NTLA is experiencing slight selling pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

The Editas Medicine share price today is $3.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.68	Sell
Relative Strength Index (14 RSI):	46.81	Sell
Chaikin Money Flow:	-614154	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(20.8 - 23.22)	Sell
Bollinger Bands (100):	(21.69 - 25.41)	Sell

EDIT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.17	Sell
Relative Strength Index (14 RSI):	46.15	Sell
Chaikin Money Flow:	-461984	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.62 - 3.98)	Buy
Bollinger Bands (100):	(4.15 - 5.65)	Sell

NTLA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	20.64	Buy
20-day SMA:	21.96	Sell
50-day SMA:	23.39	Sell
200-day SMA:	25.62	Sell
8-day EMA:	21.14	Buy
20-day EMA:	21.69	Sell
50-day EMA:	22.73	Sell
200-day EMA:	26.16	Sell

EDIT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.71	Buy
20-day SMA:	3.77	Buy
50-day SMA:	4.48	Sell
200-day SMA:	6.69	Sell
8-day EMA:	3.77	Buy
20-day EMA:	3.85	Sell
50-day EMA:	4.3	Sell
200-day EMA:	6.1	Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.

Intellia Therapeutics Technical Analysis

	Sep 3	Sep 4	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16
	Sep
	03	04	05	06	09	10	11	12	13	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

	Sep 3	Sep 4	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16
	Sep
	03	04	05	06	09	10	11	12	13	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):